Page last updated: 2024-08-24

2',3'-dideoxyadenosine triphosphate and HIV

2',3'-dideoxyadenosine triphosphate has been researched along with HIV in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balzarini, J; Eschbach, A; Halazy, S; Navé, JF; Wolff-Kugel, D1
Nair, V; Sells, TB1
Ahluwalia, G; Broder, S; Cooney, DA; Dalal, M; Flora, KP; Fridland, A; Hao, Z; Johns, DG; Mitsuya, H1

Other Studies

3 other study(ies) available for 2',3'-dideoxyadenosine triphosphate and HIV

ArticleYear
Enzymatic phosphorylation and pyrophosphorylation of 2',3'-dideoxyadenosine-5'-monophosphate, a key metabolite in the pathway for activation of the anti-HIV (human immunodeficiency virus) agent 2',3'-dideoxyinosine.
    Biochemical pharmacology, 1994, Sep-15, Volume: 48, Issue:6

    Topics: Adenosine Triphosphate; Adenylate Kinase; Animals; Biotransformation; Deoxyadenine Nucleotides; Didanosine; Dideoxynucleotides; Escherichia coli; HIV; Kinetics; Phosphorylation; Rats; Ribose-Phosphate Pyrophosphokinase; Substrate Specificity

1994
Interpretation of the roles of adenylosuccinate lyase and of AMP deaminase in the anti-HIV activity of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
    Biochimica et biophysica acta, 1992, Feb-26, Volume: 1119, Issue:2

    Topics: Adenosine; Adenylosuccinate Lyase; AMP Deaminase; Deoxyadenine Nucleotides; Didanosine; Dideoxyadenosine; Dideoxynucleotides; HIV; Succinates

1992
Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity.
    Biochemical pharmacology, 1987, Nov-15, Volume: 36, Issue:22

    Topics: Alanine; Animals; Cell Line; Chromatography, High Pressure Liquid; Deoxyadenine Nucleotides; Deoxyribonucleotides; Didanosine; Dideoxynucleotides; HIV; Inosine; Nucleotides; T-Lymphocytes

1987